Cargando…

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists

We sought to determine direct vascular effects of peroxisome proliferator-activated receptor alpha (PPARα) agonists using isolated mouse aortas and middle cerebral arteries (MCAs). The PPARα agonists GW7647, WY14643, and gemfibrozil acutely relaxed aortas held under isometric tension and dilated pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silswal, Neerupma, Parelkar, Nikhil K., Wacker, Michael J., Badr, Mostafa, Andresen, Jon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447381/ https://www.ncbi.nlm.nih.gov/pubmed/23008696 http://dx.doi.org/10.1155/2012/302495

Ejemplares similares

Restoration of Endothelial Function in Pparα (−/−) Mice by Tempol
por: Silswal, Neerupma, et al.
Publicado: (2015)

Relaxation of human pulmonary arteries by PPARγ agonists
por: Kozłowska, Hanna, et al.
Publicado: (2013)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Role of PPARα and Its Agonist in Renal Diseases
por: Cheng, Ching-Feng, et al.
Publicado: (2010)

PPARα Agonist Oral Therapy in Diabetic Retinopathy
por: Tomita, Yohei, et al.
Publicado: (2020)

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
por: Yamashita, Masamichi
Publicado: (2008)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

A PPARα agonist improves metabolic parameters in obesity
Publicado: (2012)

Dual PPAR α/γ Agonists: Continuing Cardiac Concerns
por: Balachandran, Karthik
Publicado: (2019)

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
por: Scatena, Roberto, et al.
Publicado: (2008)

The Role of PPARα Activation in Liver and Muscle
por: Burri, Lena, et al.
Publicado: (2010)

PPARα and Effects of TCE
por: Klaunig, James E., et al.
Publicado: (2007)

PPARα-independent effects of nitrate supplementation on skeletal muscle metabolism in hypoxia()
por: O'Brien, Katie A., et al.
Publicado: (2019)

Metabolomics of the interaction between PPAR-α and age in the PPAR-α-null mouse
por: Atherton, Helen J, et al.
Publicado: (2009)

MBX-102/JNJ39659100, a Novel Non-TZD Selective Partial PPAR-γ Agonist Lowers Triglyceride Independently of PPAR-α Activation
por: Chandalia, Apurva, et al.
Publicado: (2009)

Therapeutic potential of PPARα agonist in ligature-induced experimental periodontitis
por: Chen, Ying, et al.
Publicado: (2022)

Prostacyclin and PPARα Agonists Control Vascular Smooth Muscle Cell Apoptosis and Phenotypic Switch through Distinct 14-3-3 Isoforms
por: Chen, Yen-Chung, et al.
Publicado: (2013)

An Ideal PPAR Response Element Bound to and Activated by PPARα
por: Tzeng, John, et al.
Publicado: (2015)

IL-15 Mediates Mitochondrial Activity through a PPARδ-Dependent-PPARα-Independent Mechanism in Skeletal Muscle Cells
por: Thornton, Shantaé M., et al.
Publicado: (2016)

Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects
por: Rosen, Mitchell B., et al.
Publicado: (2010)

Structural Basis for PPARs Activation by The Dual PPARα/γ Agonist Sanguinarine: A Unique Mode of Ligand Recognition
por: Tian, Siyu, et al.
Publicado: (2021)

Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models
por: Jain, Mukul R, et al.
Publicado: (2015)

Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPARα Agonist with Moderate PPARγ Agonist Activity in Healthy Human Subjects
por: Jani, Rajendra H., et al.
Publicado: (2013)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARα + γ Agonists
por: Oleksiewicz, Martin B., et al.
Publicado: (2008)

Skeletal Muscle, but not Cardiovascular Function, Is Altered in a Mouse Model of Autosomal Recessive Hypophosphatemic Rickets
por: Wacker, Michael J., et al.
Publicado: (2016)

PPARs in Viral Disease
por: Capeau, Jacqueline, et al.
Publicado: (2009)

Effect of berberine on PPAR(α)-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV
por: Qiu, Hongmei, et al.
Publicado: (2016)

Genetic Variation of PPARs
por: Vohl, Marie-Claude, et al.
Publicado: (2009)

The Effect of PPARα, PPARδ, PPARγ, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice
por: Harrington, W. Wallace, et al.
Publicado: (2007)

The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
por: Porcuna, Jesús, et al.
Publicado: (2021)

PPARα- and DEHP-Induced Cancers
por: Ito, Yuki, et al.
Publicado: (2008)

PPARα Induces the Expression of CAR That Works as a Negative Regulator of PPARα Functions in Mouse Livers
por: Shizu, Ryota, et al.
Publicado: (2023)

Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist
por: Wölkart, G, et al.
Publicado: (2012)

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
por: Chen, Ying, et al.
Publicado: (2013)

The whole transcriptome effects of the PPARα agonist fenofibrate on livers of hepatocyte humanized mice
por: de la Rosa Rodriguez, Montserrat A., et al.
Publicado: (2018)

A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia
por: Balakumar, Pitchai, et al.
Publicado: (2019)

PXR Suppresses PPARα-Dependent HMGCS2 Gene Transcription by Inhibiting the Interaction between PPARα and PGC1α
por: Shizu, Ryota, et al.
Publicado: (2021)

Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers
por: Gendy, Marie N. S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tqgvdvj7bp55c3to9sl6tre4k7